Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm.

about

A selective antagonist of prostaglandin E receptor subtype 4 attenuates abdominal aortic aneurysm

P2860

Q58721049-1B2304E5-29D7-435B-A01F-D92A67531302

P2860

Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm.

Item

http://www.wikidata.org/entity/Q47760731

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm.

@en

Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm.

@nl

type

Item

label

Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm.

@en

Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm.

@nl

altLabel

Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm

@en

prefLabel

Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm.

@en

Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm.

@nl

P1476

Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm.

@en

P2093

Akira Furutani

http://www.w3.org/2001/XMLSchema#string

Bungo Shirasawa

http://www.w3.org/2001/XMLSchema#string

Kimikazu Hamano

http://www.w3.org/2001/XMLSchema#string

Koichi Yoshimura

http://www.w3.org/2001/XMLSchema#string

Noriyasu Morikage

http://www.w3.org/2001/XMLSchema#string

Shizuka Nishino-Fujimoto

http://www.w3.org/2001/XMLSchema#string

P2860

The influence of indomethacin on the metabolism and cytokine secretion of human aneurysmal aorta

Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms

Long term stabilization of expanding aortic aneurysms by a short course of cyclosporine A through transforming growth factor-beta induction

Periostin links mechanical strain to inflammation in abdominal aortic aneurysm

D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization.

Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation.

Systematic review and meta-analysis of the effects of statin therapy on abdominal aortic aneurysms.

Association of statin prescription with small abdominal aortic aneurysm progression.

Medical management of small abdominal aortic aneurysms

Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression

P304

1265-1275

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1389450119666171227223331

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29284386

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

drug discovery

molecular medicine

P932

6182934

http://www.w3.org/2001/XMLSchema#string

Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm.

about

P2860

P2860

Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm.

description

name

type

label

altLabel

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932